Moleculin Biotech sets 1-for-20 reverse stock split for Oct. 20
MBRX•Moleculin Biotech will implement a 1-for-20 reverse stock split effective October 20, reducing outstanding common shares from approximately 20.9 million to 1.05 million while authorized shares remain at 500 million.
1. Reverse split details
The split will take effect at 12:01 a.m. Eastern Time on October 20, 2026, and shares will begin split-adjusted trading on the Nasdaq Capital Market that day under the existing ticker MBRX. Fractional shares will be paid in cash.
